CSBR News and Press, Champions Oncology Inc. From 03/11/25

2025-03-11 20:07:06 ET Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Conference Call March 11, 2025 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Maj Soueidan - GeoInvesting George Marema - Par...

2025-03-11 16:32:41 ET More on Champions Oncology Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Champions Oncology H...

HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2025, ended January 31, 2025...

Algoma Steel Group Inc. (ASTL) is expected to report $0.06 for Q3 2025 E.W. Scripps Company (The) (SSP) is expected to report for Q4 2024 TransAct Technologies Incorporated (TACT) is expected to report $-0.1 for Q4 2024 Kindly MD, Inc. (KDLY) is expected to report for Q4 2024 Talo...

HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the third quarter ended January 31, 2025, on ...

2025-02-23 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-02-23 12:16:08 ET More on S&P 500 Index S&P 500 Snapshot: Worst Day Of 2025 Weekly Indicators: The Beginning Of The End Of 'Steady As She Goes?' Underpricing The Risk Of Deflation Ukraine's Zelenskyy says he's prepared to resign for NATO membersh...

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the acceptance of seventeen abstracts for presentation at the AACR Annual Meeting, in Chicago, IL (Apri...

HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to announce significant advancements in its bioanalytical services portfolio, specifically, expanding it...

2025-01-03 13:28:58 ET More on Invesco Exchange-Traded Fund Trust II - Invesco S&P 500 Momentum ETF: SPMO: 5 Reasons Why This ETF Is A Buy SPMO: This Is Really Impressive SPMO: One Of The Best Constructed ETFs In The Market Seeking Alpha’s Quant Ra...